HTL Biotechnology joins the Choiseul Conquérants 2025 ranking
HTL Biotechnology is recognized for the second consecutive year among France’s most dynamic and innovative mid-sized companies.
Press releases
May 10, 2021
Terasaki Institute Memorandum of Uderstanding
“The Terasaki Institute leads the world in the development of bioprintable, biopolymer-based technologies poised to revolutionize drug delivery, wearable and implantable devices. Jointly with HTL we expect to bring to life a new generation of biopolymer-based applications in critical sectors of precision and regenerative medicine,” added Maurizio Vecchione, Chief Innovation Officer of the Terasaki Institute for Biomedical Innovation.
Read more below.
To see our most recent news,
follow us on LinkedIn
Read more
news from us
-
Articles December 12, 2025HTL Biotechnology joins the Choiseul Conquérants 2025 ranking
HTL Biotechnology is recognized for the second consecutive year among France’s most dynamic and innovative mid-sized companies.
-
Articles October 29, 2025HTL Inside Webinar: a success that boosts our visibility in Asia
On October 28, 2025, HTL Biotechnology hosted its first-ever webinar, “Shaping the Future of Aesthetic Medicine with Premium Biopolymers,” a key initiative to strengthen our presence in Asia and promote the “Feel the Difference with HTL Inside” positioning among major players in aesthetic medicine.
-
Articles October 9, 2025HTL Biotechnology rallies for Pink October 2025
This October, HTL Biotechnology turned pink to support breast cancer prevention.